Ad hoc-Release according § 15 WpHG: MediClin AG: Despite increased Group sales the preliminary Group operating result is below expectations

Group sales of the first nine months of FY 2012 increased by 4.4 percent

Group sales of the first half-year of 2012 increased by EUR 11.2 million up to EUR 254.1 million

The Company strategy of MediClin is a model of success

Sales increased by EUR 5.4 million in the first Quarter of 2012

Dr. Ulrich Wandschneider shall become Chairman of the Supervisory Board of MediClin

Business Development of MediClin in FY 2011

MediClin: Sales increased by 1.3 %– Result below previous year’s level

Frank Abele, CFO of MediClin AG, is the new CEO

Sales in the first nine months of 2011 increased by 1.3 percent